Israeli-Found Firm Immunai Raises $215M For Its Drug Discovery Platform
The new infusion of capital will be used to expand Immunai’s “drug actuary” platform for target validation and evaluation.
October 28, 2021
Biotech Startup Immunai Raises $60M To Fuel Growth Of Drug Discovery Platform
Founded in 2018, Immunai is on a mission to map out the immune system to improve immunotherapies and discover new treatments.
February 16, 2021
